Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
M Reid, YJP Agbassi, N Arinaminpathy, A Bercasio… - The Lancet, 2023 - thelancet.com
Although COVID-19 has undermined global progress, many African countries have
sustained declines in tuberculosis mortality rates. With excellent short-course preventive …
sustained declines in tuberculosis mortality rates. With excellent short-course preventive …
Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open …
Summary Background In India, tuberculosis and undernutrition are syndemics with a high
burden of tuberculosis coexisting with a high burden of undernutrition in patients and in the …
burden of tuberculosis coexisting with a high burden of undernutrition in patients and in the …
The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience
Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts,
particularly in Africa where the disease remains out of control. The dogma that DR-TB …
particularly in Africa where the disease remains out of control. The dogma that DR-TB …
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease …
JR Ledesma, J Ma, M Zhang, AVL Basting… - The Lancet Infectious …, 2024 - thelancet.com
Background Global evaluations of the progress towards the WHO End TB Strategy 2020
interim milestones on mortality (35% reduction) and incidence (20% reduction) have not …
interim milestones on mortality (35% reduction) and incidence (20% reduction) have not …
Diabetes and tuberculosis: an emerging dual threat to healthcare
S Shetty, JM Pappachan… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Tuberculosis (TB) remains a huge global healthcare challenge even in the 21st century
though the prevalence has dropped in developed countries in recent decades. Diabetes …
though the prevalence has dropped in developed countries in recent decades. Diabetes …
Drug exposure and treatment outcomes in patients with multidrug-resistant tuberculosis and diabetes mellitus: a multicenter prospective cohort study from China
Y Zhu, LD Forsman, C Chen, H Zhang… - Clinical Infectious …, 2024 - academic.oup.com
Background The management of multidrug-resistant tuberculosis (MDR-TB) remains
challenging. Treatment outcome is influenced by multiple factors; the specific roles of …
challenging. Treatment outcome is influenced by multiple factors; the specific roles of …
Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach
A Mahapatra, K Thiruvengadam, D Nair… - Plos one, 2024 - journals.plos.org
Background By encouraging treatment adherence and lowering mortality, dietary
supplements can serve as adjuvant therapy for the success of medical interventions. We …
supplements can serve as adjuvant therapy for the success of medical interventions. We …
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
O Korotych, J Achar, E Gurbanova… - The Lancet Infectious …, 2024 - thelancet.com
Background In 2020, WHO guidelines prioritised the use of a standard fully oral short
treatment regimen (STR) consisting of bedaquiline, levofloxacin or moxifloxacin …
treatment regimen (STR) consisting of bedaquiline, levofloxacin or moxifloxacin …
Population-wide active case finding as a strategy to end TB
Tuberculosis (TB) is the leading infectious cause of morbidity and mortality globally. Despite
available tools for preventing, finding, and treating TB, many people with TB remain …
available tools for preventing, finding, and treating TB, many people with TB remain …
[HTML][HTML] Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine
OS Pedersen, T Butova, V Kapustnyk… - Clinical Microbiology …, 2024 - Elsevier
Objectives To describe demographics, clinical features, and treatment outcomes of patients
with highly drug-resistant tuberculosis (TB) in Ukraine, and to evaluate risk factors for an …
with highly drug-resistant tuberculosis (TB) in Ukraine, and to evaluate risk factors for an …